RIvaroxaban and VAscular Surgery (RIVAS): insights from a multicenter, worldwide web-based survey
Int Angiol. 2024 Jan 31. doi: 10.23736/S0392-9590.24.05146-0. Online ahead of print.NO ABSTRACTPMID:38298049 | DOI:10.23736/S0392-9590.24.05146-0 (Source: International Angiology)
Source: International Angiology - February 1, 2024 Category: Cardiology Authors: Nicola Troisi Giulia Bertagna Raffaella Berchiolli RIVAS Collaborative Study Group Source Type: research
Predictors and outcomes of deep venous thrombosis in patients with acute ischemic stroke: results from the Chinese Stroke Center Alliance
CONCLUSIONS: This large-scale, multi-center study showed that the occurrence of DVT in AIS patients is associated with various modifiable and objective indicators, such as abnormal INR and uric acid >420 μmol/L. Ambulatory status and early antithrombotic therapy can reduce the occurrence of DVT in AIS patients. In AIS patients, DVT may prolong the hospital stay and increase the risk of in-hospital mortality. Future research should focus on the clinical implementation of existing evidence on DVT prevention in AIS patients.PMID:38226943 | DOI:10.23736/S0392-9590.23.05077-0 (Source: International Angiology)
Source: International Angiology - January 16, 2024 Category: Cardiology Authors: Weixin Cai Ran Zhang Yongjun Wang Zixiao Li Liping Liu Hongqiu Gu Kaixuan Yang Xin Yang Chunjuan Wang Anxin Wang Weige Sun Yunyun Xiong Source Type: research
Reduction of lower-limb edema in patients with chronic venous disease by micronized purified flavonoid fraction: a systematic literature review and meta-analysis
CONCLUSIONS: MPFF appeared to be effective in reducing ankle and calf circumference as well as feeling of swelling irrespective of study design. The circumference reduction is present at short and long term, suggesting that benefit occurs early and is maintained overtime. Despite the observed heterogeneity among included studies, this meta-analysis supports the significant therapeutic efficacy of MPFF in reducing lower-limb edema in patients with CVD. The complete video presentation of the work is available online at www.minervamedica.it (Supplementary Digital Material 1: Supplementary Video 1, 5 min, 192 MB).PMID:38131655...
Source: International Angiology - December 22, 2023 Category: Cardiology Authors: Eberharde Rabe Vanessa Blanc-Guillemaud Marie-Blanche Onselaer Yoann Blangero Hurrem-Pelin Yaltirik Andrew Nicolaides Source Type: research
Reduction of lower-limb edema in patients with chronic venous disease by micronized purified flavonoid fraction: a systematic literature review and meta-analysis
CONCLUSIONS: MPFF appeared to be effective in reducing ankle and calf circumference as well as feeling of swelling irrespective of study design. The circumference reduction is present at short and long term, suggesting that benefit occurs early and is maintained overtime. Despite the observed heterogeneity among included studies, this meta-analysis supports the significant therapeutic efficacy of MPFF in reducing lower-limb edema in patients with CVD. The complete video presentation of the work is available online at www.minervamedica.it (Supplementary Digital Material 1: Supplementary Video 1, 5 min, 192 MB).PMID:38131655...
Source: International Angiology - December 22, 2023 Category: Cardiology Authors: Eberharde Rabe Vanessa Blanc-Guillemaud Marie-Blanche Onselaer Yoann Blangero Hurrem-Pelin Yaltirik Andrew Nicolaides Source Type: research
